Effectiveness of Cognitive Behavioral Therapy (CBT) for Child Anxiety Disorders in Community Clinics in Norway

September 24, 2018 updated by: Simon-Peter Neumer, Regionsenter for barn og unges psykiske helse

Effectiveness of Group and Individual Treatment of Childhood Anxiety Disorders in Community Clinics. A Randomized Controlled Trial.

The purpose of this study is to assess the effectiveness of a cognitive-behavioral intervention for children aged 7 to 12 years with anxiety disorders who are referred to ordinary community clinics. The treatment will be conducted as individual therapy or group therapy.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

165

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Norway
      • Lorenskog, Norway, 1478
        • Akershus Universitetssykehus HF
      • Rud, Norway, 1309
        • Sykehuset Asker og Baerum, Baerum BUP
      • Skien, Norway
        • Sykehus Telemark Helseforetak, Skien og Porsgrunn BUP

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 12 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Primary diagnosis of separation anxiety disorder, social phobia or generalized anxiety disorder based on the ADIS interview schedule, DSM-IV criteria

Exclusion Criteria:

  • Pervasive Developmental Disorder
  • Psychotic symptoms
  • Intelligence score < 70
  • Use of medications with anxiety reducing effects during treatment
  • Neither parent competent in Norwegian language

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: A
Individual CBT
Behavioral: Cognitive behavioral therapy (individual)
The Coping Cat program, 12 weekly sessions, two additional parent meetings
Experimental: B
Group CBT
Behavioral: Cognitive behavioral therapy (group)
The Coping Cat program, 12 weekly sessions, two additional parent meetings
No Intervention: C
Waiting-list control

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Status of primary anxiety disorder at inclusion based on the ADIS interview schedule with parents and youth
Time Frame: post-treatment and 2 year follow-up
post-treatment and 2 year follow-up

Secondary Outcome Measures

Outcome Measure
Time Frame
Symptom score on the MASC
Time Frame: post-treatment and 2 year follow-up
post-treatment and 2 year follow-up
CGAS
Time Frame: post-treatment and 2 year follow-up
post-treatment and 2 year follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Regionsenter for barn og unges psykiske helse

Collaborators

The Research Council of Norway

Investigators

  • Principal Investigator: Simon-Peter Neumer, dr.philos, Regionsenter for barn og unges psykiske helse

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2008

Primary Completion (Actual)

October 1, 2013

Study Completion (Actual)

December 1, 2013

Study Registration Dates

First Submitted

August 13, 2008

First Submitted That Met QC Criteria

August 13, 2008

First Posted (Estimate)

August 15, 2008

Study Record Updates

Last Update Posted (Actual)

September 26, 2018

Last Update Submitted That Met QC Criteria

September 24, 2018

Last Verified

September 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 186036/V50
  • 186036 (Other Grant/Funding Number: Norwegian Research Council)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Generalized Anxiety Disorder

Clinical Trials on Cognitive behavioral therapy (individual)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe